Biocon Stock Performance
as on May 13, 2026 at 9:31 pm IST
Day's Low
Day's High
₹402.85₹420.25
3.53%
Downside
0.63%
Upside

52 Week's Low
52 Week's High
₹317.90₹424.95
23.87%
Downside
1.76%
Upside

Biocon share price movements today
- Previous Close
- ₹402.45
- Open
- ₹403.05
- Volume
- 1.14Cr
- Upper Circuit
- ₹442.65
- Lower Circuit
- ₹362.25
- Day's Low - High
- ₹402.85 - ₹420.25
- 52 Week Low - High
- ₹317.90 - ₹424.95
Biocon Historical Returns
- 1 Month Return
- + 16.65 %
- 3 Month Return
- + 6.48 %
- 1 Year Return
- + 22.01 %
- 3 Year Return
- + 62.31 %
- 5 Year Return
- + 3.51 %
Biocon Fundamentals
as on May 13, 2026 at 4:01 pm IST
Market Cap
₹65,233.43 Cr
Return on Equity (ROE)
0.4
PE Ratio (TTM)
144.25
Return on capital employed (ROCE)
2.07
Industry PE ratio
45.31
Beta (LTM)
0.76
P/B Ratio
3.55
Dividend Yield
0.15
PEG Ratio
-25.4
Quarterly Earnings Growth YOY
-56.77
EPS (TTM)
11.91
Sector
Pharmaceuticals
Book Value
180.27
Biocon Stock Valuation
as on May 13, 2026 at 4:01 pm IST
Biocon in the last 5 years
Lowest (24.48x)
March 19, 2024
Industry (45.31x)
May 12, 2026
Today (144.25x)
May 12, 2026
Highest (144.25x)
May 12, 2026
Today’s Price to Earnings Ratio: 144.25x
Biocon Technical Analysis
Track how Biocon technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | -0.48 | |
CCI (20) | -430.65 | Bullish |
RSI (14) | 42.57 | Neutral |
Momentum (10) | -0.45 | Bullish |
ADI (14) | 39.5 | |
Ultimate Oscillator (7,14,28) | 68.82 | Neutral |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 417.56 | |
EMA (20) | 417.46 | |
VWMA (20) | 417.27 | |
SMA (50) | 418.44 | |
EMA (50) | 418.01 | |
SMA (200) | 417.4 | |
EMA (200) | 417.04 | |
KAMA (200) | 418.11 | |
DEMA (200) | 419.61 |
Biocon Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Biocon with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 65,233.43 | 0.7% | 0.78 | 1,429 | 15,261 | |
| BUY | 1,76,377.32 | 13.05% | 0.50 | 2,191 | 9,360 | |
| BUY | 1,48,303.41 | 44.39% | 0.66 | 1,911 | 11,516 | |
| BUY | 30,844.05 | -6.93% | 0.53 | 698 | 5,616 | |
| BUY | 1,04,389.75 | 8.59% | 0.51 | 5,291 | 27,547 |
Market expectation of Biocon Stock
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
53.33%
Buy
20.00%
Hold
26.67%
Sell
Biocon Stock’s Investor Sentiment and Interest
Investment in Biocon Ltd Shares on INDmoney has grown by 55.61% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:55.61% versus previous 30 day period
Search interest for Biocon Ltd Stock has increased by 13% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:13% versus previous 30 day period
Biocon Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Biocon Ltd Annual Profit & Loss
Figures in Rupees Crores
Biocon Ltd Cash Flow
Figures in Rupees Crores
Biocon Corporate Actions
View detailed summary of the earnings and dividend history of Biocon.
Biocon Ltd Earnings Results
Biocon Ltd’s net profit fell -63.45% since last year same period to ₹125.90Cr in the Q4 2025-2026. On a quarterly growth basis, Biocon Ltd has generated -12.45% fall in its net profits since last 3-months.
Read More about Earnings ResultsBiocon Ltd Dividends May,2025
In the quarter ending March 2025, Biocon Ltd has declared dividend of ₹0.50 per share on 08 May 2025 - translating a dividend yield of 0.25%.
Read More about Dividends
Biocon News & Key Events

Today's Timeline - 13 May
08:48 AM
-Biocon breaks above five-month downtrend, indicating bullish sentiment with expected upside of Rs 425-440.
10:04 AM
-Biocon gains 1.38% on BSE to ₹407.70, reflecting positive market sentiment.
01:05 PM
-Biocon up 3.7%, marking third consecutive session of gains, with significant volume increase.

Today's Timeline - 13 May
01:54 PM
-Biocon stock rallies 10% in three days, nearing 52-week high after Health Canada approval.
05:17 PM
-Analyst Jain highlights Biocon's potential breakout above Rs 416, recommending it as a strong investment.
Indices Featuring Biocon Stock
Check stock indices that include Biocon.
Insights on Biocon Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 1 Year

In the last 1 year, BIOCON has outperformed top 5 stocks with highest market-cap in Biotechnology & Medical Research
POSITIVE IMPACTPrice Rise

In the last 7 days, BIOCON stock has moved up by 5.7%
POSITIVE IMPACTFII Holding Up

Foreign Institutions have increased holdings from 7.14% to 7.52% in Mar 2026 quarter
POSITIVE IMPACTRevenue Rich

Revenue is up for the last 2 quarters, 4.29K Cr → 4.56K Cr (in ₹), with an average increase of 6.1% per quarter
NO EFFECTAgainst Peers

In the last 3 years, Vimta Labs Ltd has given 150.9% return, outperforming this stock by 88.5%
NO EFFECTPromoter Holding Unchanged

Promoters holdings remained unchanged at 44.91% of holdings in Mar 2026 quarter
NEGATIVE IMPACTRetail Holding Down

Retail Investor have decreased holdings from 23.69% to 23.41% in Mar 2026 quarter
NEGATIVE IMPACTMF Holding Down

Mutual Funds have decreased holdings from 17.03% to 16.53% in Mar 2026 quarter
NEGATIVE IMPACTProfit Down

Netprofit is down for the last 2 quarters, 143.8 Cr → 125.9 Cr (in ₹), with an average decrease of 12.5% per quarter
Biocon Stock Futures & Options Contracts
View the latest movement in Biocon Futures & Options, including strike prices, expiry dates, and percentage changes.
Biocon Options
Biocon Futures
About Biocon Ltd
Biocon's top products include insulin, monoclonal antibodies, enzymes, and vaccines. Its popular brands include Insugen, Insupen, and Insugen Plus. The company has a strong presence in the Indian market and is expanding its reach to other countries. Biocon has also established its presence in the US, Europe, and Japan.
Revenue: ₹4,484.30Cr as on March 2026 (Q4 FY26)
Net Profit: ₹198.60Cr as on March 2026 (Q4 FY26)
Listing date: 07 Apr, 2004
Chairperson Name: Kiran Mazumdar Shaw
| Organisation | Biocon Ltd |
| Headquarters | Bangalore |
| Industry | Pharmaceuticals |
| CEO | Kiran Mazumdar Shaw |
| E-voting on shares | Click here to vote |
FAQs
What is Biocon share price today?
Biocon share price today stands at ₹417.6 as on at the close of the market. Biocon share today touched a day high of ₹420.25 and a low of ₹402.85.
What is the 52 week high and 52 week low range for Biocon share?
Biocon touched a 52 week high of ₹424.95 and a 52 week low of ₹317.9. Biocon share price today i.e. is closed at ₹417.6, which is -1.73% down from its 52 week high and 31.36% up from its 52 week low.
What is Biocon's market capitalisation today?
Biocon market capitalisation is ₹65,233.43 Cr as on .
How to buy Biocon shares?
To buy Biocon shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for BIOCON or Biocon Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Biocon shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Biocon trading volume today?
Biocon trading volume is 1.14Cr as on . This means that 1.14Cr shares of Biocon were bought and sold on the stock market during today's trading session.